StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mylan (MYL) Announces Actions to Expand EpiPen Access; Includes Plans to Reduce Patient Cost
August 25, 2016 7:01 AM
Mylan N.V. (Nasdaq: MYL) announced it is taking immediate action to further enhance access to EpiPen® (epinephrine injection, USP) Auto-Injector ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Hot Corp. News
Management Comments
Next Articles
Elijah Cummings Says Mylan's (MYL) Meager Discount Merely 'PR Move'
August 25, 2016 10:42 AM
Mylan's (MYL) Steps on EpiPen Do Not Go Far Enough - Wells Fargo's Maris
August 25, 2016 10:33 AM
Mylan (MYL) volatile amid CEO interview on CNBC
August 25, 2016 8:34 AM
Mylan (MYL) Gains Early After Taking Action on EpiPen Pricing
August 25, 2016 7:51 AM
Mylan Taking Immediate Action to Further Enhance Access to EpiPen® (Epinephrine Injection, USP) Auto-Injector
August 25, 2016 7:00 AM
